Topline:
The U.S. took the unprecedented step Monday of dropping the number of vaccines it recommends for every child — cutting protection against a half-dozen diseases in a move slammed by the nation’s pediatricians.
The changes: The overhaul is effective immediately, meaning that the Centers for Disease Control and Prevention will now recommend vaccines against 11 diseases.
What’s no longer broadly recommended: Protection against flu, rotavirus, hepatitis A, hepatitis B, some forms of meningitis or RSV. Instead, protections against those diseases are only recommended for certain groups deemed high-risk, or if their doctors recommend them in what’s called “shared decision-making.”
Why now: The change came after President Donald Trump in December asked the U.S. Department of Health and Human Services to review how peer nations approach vaccine recommendations and consider revising its guidance to align with theirs. HHS said its comparison to 20 peer nations found that the U.S. was an “outlier” in both the number of vaccinations and the number of doses it recommended to all children. Officials with the agency framed the change as a way to increase public trust by recommending only the most important vaccinations for children to receive.
The U.S. took the unprecedented step Monday of dropping the number of vaccines it recommends for every child — cutting protection against a half-dozen diseases in a move slammed by the nation’s pediatricians.
The overhaul is effective immediately, meaning that the Centers for Disease Control and Prevention will now recommend vaccines against 11 diseases. What’s no longer broadly recommended is protection against flu, rotavirus, hepatitis A, hepatitis B, some forms of meningitis or RSV. Instead, protections against those diseases are only recommended for certain groups deemed high-risk, or if their doctors recommend them in what’s called “shared decision-making.”
Trump administration officials said the overhaul, a move long sought by Health Secretary Robert F. Kennedy Jr., won’t result in families who want the vaccines losing access to them, and said insurance will continue to pay. But medical experts said the move increases confusion for parents and could increase preventable diseases.
The change came after President Donald Trump in December asked the U.S. Department of Health and Human Services to review how peer nations approach vaccine recommendations and consider revising its guidance to align with theirs.
HHS said its comparison to 20 peer nations found that the U.S. was an “outlier” in both the number of vaccinations and the number of doses it recommended to all children. Officials with the agency framed the change as a way to increase public trust by recommending only the most important vaccinations for children to receive.
Among those left on the recommended-for-everyone list are measles, whooping cough, polio, tetanus, chickenpox and HPV.
“This decision protects children, respects families, and rebuilds trust in public health,” Kennedy said in a statement Monday.
Medical experts disagreed, saying the change without public discussion or a transparent review of the data would put children at risk.
Dr. Sean O’Leary of the American Academy of Pediatrics said countries carefully consider vaccine recommendations based on levels of disease in their populations and their health systems.
“You can’t just copy and paste public health and that’s what they seem to be doing here,” said O’Leary. “Literally children’s health and children’s lives are at stake.”
The new guidance also reduces the number of recommended vaccine doses against human papillomavirus from two or three shots to one for most children, depending on age.
The decision was made without input from an advisory committee that typically consults on the vaccine schedule, said senior officials at HHS. The officials spoke on the condition of anonymity because they weren’t authorized to discuss the changes publicly.
“Abandoning recommendations for vaccines that prevent influenza, hepatitis and rotavirus, and changing the recommendation for HPV without a public process to weigh the risks and benefits, will lead to more hospitalizations and preventable deaths among American children,” said Michael Osterholm of the Vaccine Integrity Project, based at the University of Minnesota.
